Apoptosis, proliferation and Fas ligand expression in placental trophoblast from pregnancies complicated by HELLP syndrome or pre-eclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 10, 2011, Pages 1157-1163

  Prusac, Ivana Kuzmic ^a   Zekic Tomas, Sandra ^b   Roje, Damir ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Apoptosis; Fas ligand; HELLP syndrome; placenta; pre eclampsia; trophoblast

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FAS LIGAND; LACTATE DEHYDROGENASE;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELLP SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEINURIA; QUANTITATIVE ANALYSIS; THROMBOCYTE COUNT; TROPHOBLAST;

ADULT; APOPTOSIS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CESAREAN SECTION; FAS LIGAND PROTEIN; FEMALE; HELLP SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TROPHOBLASTS; YOUNG ADULT;

EID: 80052975064     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01152.x     Document Type: Article

References (22)

1. Curtin WM, Weinstein L,. A review of HELLP syndrome. J Perinatol. 1999; 19: 138-43.
2. Goodburn E, Campbell O,. Reducing maternal mortality in the developing world: sector-wide approaches may be the key. BMJ. 2001; 322: 917-20. (Pubitemid 32324320)
3. Sibai BM,. Hypertension in pregnancy. In:, Gabbe SG, Niebyl JR, Simpson JL, (eds). Obstetrics: normal and problem pregnancies, 3rd edn. New York: Churchill Livingstone, Inc., 1996. pp. 935-96.
4. Smulian J, Shen-Schwarz S, Scorza W, Kinzler W, Vintzileos A,. A clinicohistopathologic comparison between HELLP syndrome and severe preeclampsia. J Matern Fetal Neonatal Med. 2004; 16: 287-93. (Pubitemid 40128816)
5. Raff MC,. Social controls on cell survival and cell death. Nature. 1992; 356: 397-400.
6. Kerr JF, Gobé GC, Winterford CM, Harmon BV,. Anatomical methods in cell death. Methods Cell Biol. 1995; 46: 1-27.
7. Straszewski-Chavez SL, Abrahams VM, Mor G,. The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev. 2005; 26: 877-97. (Pubitemid 41770156)
8. Fischer U, Janicke RU, Schulze-Osthoff K,. Many cuts to ruin: a comprehensive update on caspase substrates. Cell Death Differ. 2003; 10: 76-100. (Pubitemid 36511834)
9. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, et al,. Caspases are activated in a branched protease cascade and control distinct downstream proteases in Fas-induced apoptosis. J Exp Med. 1998; 187: 587-600. (Pubitemid 28093361)
10. Sorenson CM,. Bcl-2 family members and disease. Biochim Biophys Acta. 2004; 1644: 169-77. (Pubitemid 38281273)
11. Bamberger AM, Schulte HM, Thuneke I, Edrmann I, Bamberger CM, Asa SL,. Expression of apoptosis inducing Fas ligand (FASL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab. 1997; 82: 3173-5. (Pubitemid 27385695)
12. Nagata S,. Fas and Fas ligand: a death factor and its receptor. Adv Immunol. 1994; 57: 129-44.
13. Chan CC, Lao TT, Cheung AN,. Apoptotic and proliferative activities in first trimester placentae. Placenta. 1999; 20: 223-7. (Pubitemid 29121819)
14. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA,. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000; 96: 271-6. (Pubitemid 30447352)
15. Huppertz B,. Placentalvillous trophoblast: the altered balance between proliferation and apoptosis triggers preeclampsia. J Reproduktionsmed Endocrinol. 2006; 3: 103-8. (Pubitemid 43855572)
16. Redman CW, Sacks GP, Sargent IL,. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999; 180: 499-506. (Pubitemid 29093892)
17. Payne GS, Smith CS, Davidge ST, Baker PN, Guilbert LJ,. Death receptor Fas/Apo-1/CD95 expressed by human cytotrophoblasts does not mediate apoptosis. Biol Reprod. 1999; 60: 1144-50. (Pubitemid 29196766)
18. Aschkenazi S, Straszewski S, Verwer Karlijn MA, Foellmer H, Rutheford T, Mor G,. Differential regulation and function of Fas/Fas ligand system in human trophoblast cells. Biol Reprod. 2002; 66: 1853-61. (Pubitemid 34547287)
19. Austgulen R, Isaksen CV, Chedwick L, Romundstad P, Vatten L, Craven C,. Pre-eclampsia: associated with increased syncytial apoptosis when the infant is small-forgestational-age. J Reprod Immunol. 2004; 61: 39-50. (Pubitemid 38210258)
20. Jeschke U, Schiessl B, Mylonas I, Kunze S, Kuhn C, Schulze S, et al,. Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies. Int J Gynecol Pathol. 2006; 25: 354-60. (Pubitemid 44651767)
21. Eide IP, Isaken CV, Salvesen KA, Langaas M, Gunther CC, Iversen AC, et al,. Fetal growth restriction is associated with reduced FasL expression by decidual cells. J Reprod Immunol. 2007; 74: 7-14. (Pubitemid 46680565)
22. Strand S, Strand D, Seufert R, Mann A, Lotz J, Blessing M, et al,. Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome. Gastroenterology. 2004; 126: 849-58. (Pubitemid 38298333)